`qHPV’: India to roll out first indigenously developed vaccine against Cervical Cancer today

1 min read
Screenshot 2022 09 01 123408

NEW DELHI: Serum Institute of India (SII) and the Department of Biotechnology(DBT) will roll out the first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against Cervical Cancer today.

The most awaited vaccine will be launched by the Union Minister of State (Independent Charge) Science & Technology Jitendra Singh on Thursday.

According to Dr. N K Arora, Chairperson of the COVID working group, National Technical Advisory Group on Immunisation (NTAGI) said it is an exciting experience to launch a made-in-India vaccine.

“It is very exciting and I must say it makes us very happy that our daughters and granddaughters will now be able to get this much-awaited vaccine.”

“In fact, this is one of the last major vaccines to be introduced. In fact, this is one of the last vaccines that will be launched in the programme. Now, Indian vaccines will be available and we hope that it will be launched in the National Immunisation programme for 9-14-year-old girls,” he added.

“It is very effective and prevents cervical cancer because, 85 percent to 90 percent of cases, cervical cancer is because of this particular virus, and this vaccine is against those viruses. So, if we give it to our young children and daughters, they are protected from the infection and consequently probably 30 years later, cancer does not occur,” Dr. Arora further explained.

“There was a shortage in the global market. Now Indian vaccine has come. So, we will be able to take care of our requirements within our made-in-India vaccine,” he said.

Discover more from The Kashmir Monitor

Subscribe now to keep reading and get access to the full archive.

Continue reading

Don't Miss

2022 12img21 Dec 2022 PTI12 21 2022 000141A 1

Use masks in crowded places, take precaution dose of Covid vaccine: NITI Aayog member

NEW DELHI, Dec 21: Only 27-28 per cent of India’s eligible population
Capture 6

US researchers develop new vaccine that blocks COVID-19, variants, other viruses

New York: US researchers have developed a potential new vaccine, which has